Harbor Capital Advisors’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.43M | Sell |
51,409
-50,611
| -50% | -$2.39M | 0.1% | 256 |
|
|
2025
Q1 | $3.99M | Buy |
102,020
+22,372
| +28% | +$874K | 0.18% | 177 |
|
|
2024
Q4 | $4.31M | Buy |
79,648
+2,180
| +3% | +$118K | 0.19% | 162 |
|
|
2024
Q3 | $3.91M | Buy |
77,468
+38,779
| +100% | +$1.96M | 0.17% | 175 |
|
|
2024
Q2 | $1.7M | Buy |
38,689
+30,481
| +371% | +$1.34M | 0.13% | 237 |
|
|
2024
Q1 | $412K | Buy |
+8,208
| New | +$412K | 0.05% | 447 |
|